Literature DB >> 24550272

Reciprocal interactions of human C10orf12 and C17orf96 with PRC2 revealed by BioTAP-XL cross-linking and affinity purification.

Artyom A Alekseyenko1, Andrey A Gorchakov, Peter V Kharchenko, Mitzi I Kuroda.   

Abstract

Understanding the composition of epigenetic regulators remains an important challenge in chromatin biology. Traditional biochemical analysis of chromatin-associated complexes requires their release from DNA under conditions that can also disrupt key interactions. Here we develop a complementary approach (BioTAP-XL), in which cross-linking (XL) enhances the preservation of protein interactions and also allows the analysis of DNA targets under the same tandem affinity purification (BioTAP) regimen. We demonstrate the power of BioTAP-XL through analysis of human EZH2, a core subunit of polycomb repressive complex 2 (PRC2). We identify and validate two strong interactors, C10orf12 and C17orf96, which display enrichment with EZH2-BioTAP at levels similar to canonical PRC2 components (SUZ12, EED, MTF2, JARID2, PHF1, and AEBP2). ChIP-seq analysis of BioTAP-tagged C10orf12 or C17orf96 revealed the similarity of each binding pattern with the location of EZH2 and the H3K27me3-silencing mark, validating their physical interaction with PRC2 components. Interestingly, analysis by mass spectrometry of C10orf12 and C17orf96 interactions revealed that these proteins may be mutually exclusive PRC2 subunits that fail to interact with each other or with JARID2 and AEBP2. C10orf12, in addition, shows a strong and unexpected association with components of the EHMT1/2 complex, thus potentially connecting PRC2 to another histone methyltransferase. Similarly, results from CBX4-BioTAP protein pulldowns are consistent with reports of a diversity of PRC1 complexes. Our results highlight the importance of reciprocal analyses of multiple subunits and suggest that iterative use of BioTAP-XL has strong potential to reveal networks of chromatin-based interactions in higher organisms.

Entities:  

Keywords:  LC-MS/MS; chromatin IP; formaldehyde cross-linking; protein–protein interactions

Mesh:

Substances:

Year:  2014        PMID: 24550272      PMCID: PMC3932854          DOI: 10.1073/pnas.1400648111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  A generic protein purification method for protein complex characterization and proteome exploration.

Authors:  G Rigaut; A Shevchenko; B Rutz; M Wilm; M Mann; B Séraphin
Journal:  Nat Biotechnol       Date:  1999-10       Impact factor: 54.908

2.  A gene complex controlling segmentation in Drosophila.

Authors:  E B Lewis
Journal:  Nature       Date:  1978-12-07       Impact factor: 49.962

3.  Regulation of the Polycomb protein RING1B ubiquitination by USP7.

Authors:  Prim de Bie; Daphna Zaaroor-Regev; Aaron Ciechanover
Journal:  Biochem Biophys Res Commun       Date:  2010-08-26       Impact factor: 3.575

4.  The JARID2-PRC2 duality.

Authors:  Hans-Martin Herz; Ali Shilatifard
Journal:  Genes Dev       Date:  2010-05       Impact factor: 11.361

5.  An integrated mass spectrometry-based proteomic approach: quantitative analysis of tandem affinity-purified in vivo cross-linked protein complexes (QTAX) to decipher the 26 S proteasome-interacting network.

Authors:  Cortnie Guerrero; Christian Tagwerker; Peter Kaiser; Lan Huang
Journal:  Mol Cell Proteomics       Date:  2005-11-10       Impact factor: 5.911

6.  Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation.

Authors:  Emily Walker; Wing Y Chang; Julie Hunkapiller; Gerard Cagney; Kamal Garcha; Joseph Torchia; Nevan J Krogan; Jeremy F Reiter; William L Stanford
Journal:  Cell Stem Cell       Date:  2010-02-05       Impact factor: 24.633

7.  Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice.

Authors:  Ernie de Boer; Patrick Rodriguez; Edgar Bonte; Jeroen Krijgsveld; Eleni Katsantoni; Albert Heck; Frank Grosveld; John Strouboulis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-11       Impact factor: 11.205

8.  Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor.

Authors:  Goedele N Maertens; Selma El Messaoudi-Aubert; Sarah Elderkin; Kevin Hiom; Gordon Peters
Journal:  EMBO J       Date:  2010-07-02       Impact factor: 11.598

9.  AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2.

Authors:  Hana Kim; Keunsoo Kang; Joomyeong Kim
Journal:  Nucleic Acids Res       Date:  2009-03-17       Impact factor: 16.971

10.  Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genes.

Authors:  Maxim Nekrasov; Tetyana Klymenko; Sven Fraterman; Bernadett Papp; Katarzyna Oktaba; Thomas Köcher; Adrian Cohen; Hendrik G Stunnenberg; Matthias Wilm; Jürg Müller
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

View more
  50 in total

Review 1.  Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2.

Authors:  Chiara Mozzetta; Julien Pontis; Slimane Ait-Si-Ali
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

2.  Streamlined discovery of cross-linked chromatin complexes and associated histone modifications by mass spectrometry.

Authors:  Barry M Zee; Artyom A Alekseyenko; Kyle A McElroy; Mitzi I Kuroda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

3.  Functional Proteomic Analysis of Repressive Histone Methyltransferase Complexes Reveals ZNF518B as a G9A Regulator.

Authors:  Verena K Maier; Caitlin M Feeney; Jordan E Taylor; Amanda L Creech; Jana W Qiao; Attila Szanto; Partha P Das; Nicholas Chevrier; Catherine Cifuentes-Rojas; Stuart H Orkin; Steven A Carr; Jacob D Jaffe; Philipp Mertins; Jeannie T Lee
Journal:  Mol Cell Proteomics       Date:  2015-02-13       Impact factor: 5.911

4.  C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels.

Authors:  Yi Shi; Hong-Lei Ma; You-Wen Zhuang; Xiao-Xi Wang; Yi Jiang; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2019-06-11       Impact factor: 6.150

5.  Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma.

Authors:  Artyom A Alekseyenko; Erica M Walsh; Barry M Zee; Tibor Pakozdi; Peter Hsi; Madeleine E Lemieux; Paola Dal Cin; Tan A Ince; Peter V Kharchenko; Mitzi I Kuroda; Christopher A French
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

Review 6.  Dynamic Competition of Polycomb and Trithorax in Transcriptional Programming.

Authors:  Mitzi I Kuroda; Hyuckjoon Kang; Sandip De; Judith A Kassis
Journal:  Annu Rev Biochem       Date:  2020-01-13       Impact factor: 23.643

7.  Correspondence of Drosophila polycomb group proteins with broad H3K27me3 silent domains.

Authors:  Youngsook L Jung; Hyuckjoon Kang; Peter J Park; Mitzi I Kuroda
Journal:  Fly (Austin)       Date:  2015       Impact factor: 2.160

8.  Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

Authors:  Giorgio Oliviero; Gerard L Brien; Ariane Waston; Gundula Streubel; Emilia Jerman; Darrell Andrews; Benjamin Doyle; Nayla Munawar; Kieran Wynne; John Crean; Adrian P Bracken; Gerard Cagney
Journal:  Mol Cell Proteomics       Date:  2016-09-15       Impact factor: 5.911

9.  Unique Structural Platforms of Suz12 Dictate Distinct Classes of PRC2 for Chromatin Binding.

Authors:  Siming Chen; Lianying Jiao; Murtada Shubbar; Xin Yang; Xin Liu
Journal:  Mol Cell       Date:  2018-03-01       Impact factor: 17.970

10.  BioTAP-XL: Cross-linking/Tandem Affinity Purification to Study DNA Targets, RNA, and Protein Components of Chromatin-Associated Complexes.

Authors:  Artyom A Alekseyenko; Kyle A McElroy; Hyuckjoon Kang; Barry M Zee; Peter V Kharchenko; Mitzi I Kuroda
Journal:  Curr Protoc Mol Biol       Date:  2015-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.